Egg Donor Qualifications and Disqualifications

ASRM’s 2024 guidance recommends donors be legally adult and preferably ages 21–34, while describing individualized considerations for donors outside that preferred range. It also recommends assessment of health, ovarian reserve, genetic history, and psychoeducational readiness. [1] These recommendations are not a promise that everyone within the age range will qualify or that every program accepts the same applicants.

Distinguish an agency’s application criteria from a clinic’s clearance. A donor might fit an agency’s recruitment preferences but still require clinical evaluation before a cycle. A clinic may also ask for records or additional tests after reviewing a profile. For intended parents, the useful question is not simply whether a donor is qualified. Ask who assessed which criteria, when the assessment occurred, and what remains unresolved for your proposed treatment.

Age is one factor in the clinic’s assessment of donor suitability. ASRM describes a preferred range and the importance of counseling and informed consent in circumstances outside it. [1] Do not convert that into a national legal rule. A program’s own age requirements may be narrower, and the clinic must consider the individual medical picture.

Body mass index may be considered by a clinic when assessing treatment, anesthesia, or other health-related risks. This guide does not publish a universal BMI threshold because the cited donation guidance does not establish one single cutoff for all programs. Ask the treating clinic for its current policy and the reason behind it.

For applicants, accurate disclosure is more useful than guessing what answer will qualify. A screening decision is about suitability for a particular medical process, not a judgment of a person’s worth or ability to help others.

The clinical evaluation includes medical history and examination. ASRM also emphasizes changes in health information and appropriate follow-up processes. [1] An application is a starting point for reviewing information, not a medical certification. The clinic may need records to understand an earlier diagnosis, surgery, medication, reproductive history, or previous donation.

Ask how information is collected, who reviews it, and how applicants can correct it. Do not conceal symptoms or stop prescribed medication to satisfy an assumed requirement. Questions about medication changes belong with the prescribing clinician and treating fertility team.

For intended parents, request a clear distinction between donor-reported information, documented records, and clinical conclusions. You should not infer that every profile statement was independently verified. Ask which information the clinic can share appropriately and how medical privacy is protected during review.

ASRM recommends appropriate genetic evaluation, including attention to personal and family history. [1] Genetic testing is not a test for intelligence, personality, talent, or a guaranteed healthy child. A result must be interpreted in context, often with qualified genetic counseling and information about the other genetic contributor.

A carrier result is not automatically the same as an affected individual or a universal disqualification. Your clinic and genetic counselor should explain whether a finding affects the proposed combination and what options or uncertainties remain. This guide cannot interpret a report or recommend a donor medically.

Ask which testing panel was used, whether comparison with another report is appropriate, and how updated family information can be reported later. An incomplete family history should be described as incomplete, not quietly filled in with reassuring assumptions. Even extensive testing cannot remove every possible genetic or health risk.

ASRM recommends pelvic ultrasound assessment, including antral follicle count, and additional ovarian reserve biomarkers to help anticipate response to stimulation. [1] Those measurements assist clinical planning. They do not promise a fixed number of retrieved eggs, embryos, transfers, pregnancies, or future children.

The clinic should decide which measurements it needs and how recent they must be. A number copied into a marketing profile is not enough to interpret the donor’s anticipated response. Ask the clinician to explain what the measurement can and cannot tell you and whether the proposed allocation makes sense for your goals.

Applicants should know that screening itself may reveal information requiring further discussion. Ask who will communicate results and what follow-up is available. Do not treat a preliminary assessment as consent to a cycle; the donor needs an understandable explanation of treatment and its uncertainties before deciding to proceed.

The FDA donor-eligibility framework focuses on communicable-disease risk, while ASRM recommendations include broader clinical and counseling considerations. ASRM’s 2024 guidance explains testing and documentation requirements for oocyte donation, including distinctions between directed and nondirected arrangements. [1] Clinics must evaluate the actual records and applicable requirements.

There is no screening method that guarantees an infection can never be transmitted. ASRM explicitly describes screening as risk reduction, not absolute protection. [1] Avoid interpreting a screened label as a zero-risk statement. Ask whether required testing is complete, whether timing changes will require another review, and who determines eligibility.

A matching service should not suggest bypassing clinic requirements to keep a schedule. If the medical team requests more evaluation, ask what the request means and how it affects the timeline. Only qualified professionals should explain results or decide how the treatment can proceed.

ASRM strongly recommends psychoeducational counseling by a qualified mental health professional for donors. [1] The process is not simply a personality interview. It can help assess understanding of donation, implications for future contact and family relationships, and readiness for the practical and emotional commitments involved.

Ask how counseling is arranged, what confidentiality applies, and whether the donor has space to raise concerns without pressure. A history of receiving mental health care should not be turned into an unsourced blanket disqualification on a marketing page. The evaluating professionals must consider the individual circumstances and current program policy.

Participation must remain an informed choice. A donor should understand medications, monitoring, retrieval, potential risks, compensation terms, and the possibility of cancellation. These are reasons to provide clear counseling and appropriate support, not to reduce the process to a fast acceptance checklist.

A program may decline an applicant, defer review while records are collected, or request additional evaluation. Those are different outcomes. Ask whether a decision relates to that clinic’s current criteria, incomplete information, a temporary scheduling issue, or a medical concern requiring follow-up. Not every decision has an appeal or a route to eligibility elsewhere.

For donors, enter sensitive information only in the dedicated Jotform application when requested. Do not send health or genetic records through ordinary email to ask whether you qualify. For intended parents, use a general consultation to clarify the process and request an approved private method for discussing medical details.

Before considering a donor clinically ready, ask for the clinic’s status summary: completed evaluations, pending evaluations, documentation validity, and any unresolved questions. Educational credentials or photographs do not replace that summary. Matching preferences and medical eligibility belong in separate parts of your decision.